CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 30, 2019--
Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company
focused on the development and commercialization of therapeutics for
patients with kidney disease, today announced plans to release its
financial results for the first quarter ended March 31, 2019, on
Thursday, May 9, 2019, before the opening of the financial markets.
Akebia will host a conference call at 9:00 a.m. Eastern Time on
Thursday, May 9, 2019 to discuss its first quarter financial results. To
listen to the conference call, please dial (877) 458-0977 (domestic) or
(484) 653-6724 (international) using conference ID number 4271217. The
call will also be webcast LIVE and can be accessed via the Investors
section of the Company’s website at http://ir.akebia.com.
A replay of the conference call will be available two hours after the
completion of the call through May 15, 2019. To access the replay, dial
(855) 859-2056 (domestic) or (404) 537-3406 (international) and
reference conference ID number 4271217. An online archive of the
conference call can be accessed via the Investors section of the
Company’s website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical
company focused on the development and commercialization of therapeutics
for patients with kidney disease. The company was founded in 2007 and is
headquartered in Cambridge, Massachusetts. For more information, please
visit our website at www.akebia.com, which
does not form a part of this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190430005194/en/
Source: Akebia Therapeutics, Inc.
Kristen K. Sheppard, Esq